Does dutasteride stop hair loss forever?
    Finasteride/Dutasteride 11/5/2024

    From the encyclopedia
    Dutasteride β†’

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Minoxidil β†’

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this question or advice post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 0.5mg daily more than two years
    πŸ’§ Minoxidil (topical) a few weeks
    the tone is 😐 neutral with slowed down hair loss, halted hairline recession results.

    Other terms

    Dutasteride and finasteride can significantly slow or halt hair loss, with some users experiencing regrowth, but results vary. Lifestyle factors and individual genetic predispositions also play a role in hair loss outcomes.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research The Challenging Consultation: Management of Melanoma

      May 2019 in “Australasian Journal of Dermatology”
      The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

      research Androgenic alopecia updates

      July 2023 in “International journal of dermatology, venereology and leprosy sciences”
      This review discusses the increased prevalence of androgenic alopecia in men and women, highlighting the limited FDA-approved treatment options, and reports no clinical results; the authors note adherence challenges due to prolonged drug use.

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.

      research Androgens and hair loss

      52 citations , June 2009 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the pathogenesis and treatment of androgenetic alopecia, highlighting genome associations and newer topical formulations, but reports no new clinical results.

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.